What a Long Strange Trip: The Fall and Rise of Psychedelics in Medicine – Dr. Jim Fadiman, Author and Pioneer in Psychedelic Research

The current interest in using psychedelics for mental health treatment is a ‘back to the future’ moment for Dr. Jim Fadiman, a pioneer in psychedelic research known as the father of microdosing. “The method that's been developed for administering high doses in a supervised environment is replicating exactly what we developed in the 1960s,” he tells host Shiv Gaglani. At that time, the federal government approved his research, but when the Nixon administration criminalized this class of drugs for political reasons, all research stopped, creating a wide belief that they are unsafe when actually, he says, they’re among the pharmacologically safest drugs. In the absence of government-sanctioned research, what Fadiman calls “citizen science” has been thriving. Hundreds of thousands of people have self-reported through social media and other means that the drugs improve their functioning and have no serious side effects. Other countries are sponsoring research yielding the same results. In the context of a deepening mental health crisis, Fadiman believes it makes sense to integrate psychedelics into treatment, especially when the pharmaceuticals in use are only modestly effective for a minority of patients. Make sure to listen through to the end of the episode to learn about his new book, Symphony of Selves on harmonizing different aspects of our personalities to reduce stress and increase empathy for others. This is a deeply-informed, revealing and fun conversation you won’t want to miss.